GlassScriptPhysician profile
Ronald B Sites
NPI 1316059090
$1,199.59
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $515 · 2020: $123 · 2021: $259 · 2022: $302.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $337.72 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $171.28 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $125.63 | 2019-2022 | |
| Adlon Therapeutics L.P. | $108.13 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $80.88 | 2019-2021 | |
| Lundbeck LLC | $80.72 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $73.85 | 2019 | |
| Jazz Pharmaceuticals INC. | $48.28 | 2019-2021 | |
| Neos Therapeutics, LP | $35.35 | 2019-2022 | |
| Eisai INC. | $29.59 | 2020-2021 | |
| Alkermes, INC. | $19.86 | 2022 | |
| Corium, LLC | $17.51 | 2022 | |
| Ironshore Pharmaceuticals INC. | $14.65 | 2019 | |
| Shire North American Group INC | $12.84 | 2019 | |
| Bausch Health US, LLC | $12.61 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11.76 | 2019 | |
| Arbor Pharmaceuticals, INC. | $10.99 | 2019 | |
| Brainsway USA INC | $7.94 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Sites listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.